BUSINESS LIVE: Unilever boosted by price hikes; AstraZeneca sales shy of forecasts; BAT to complete Russian business sale this year
POPULAR MONEY SECTIONS
Published: | Updated:
Some links in this article may be affiliate links. If you click on them we may earn a small commission. That helps us fund This Is Money, and keep it free to use. We do not write articles to promote products. We do not allow any commercial relationship to affect our editorial independence.
This website uses cookies. By continuing to use this site, you accept our use of cookies.